来自MSN10 小时
Castle Biosciences gains New York state approval for Barrett’s oesophagus test
Castle Biosciences' TissueCypher test predicts a patient’s risk of progression from Barrett’s oesophagus to oesophageal ...
Castle Biosciences Announces New York State Department of Health Approval of Its ...
Castle Biosciences has received assay approval from the New York State Department of Health (NYSDOH) for its TissueCypher ...